PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 54 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000 | -37.5% | 5,063 | -4.1% | 0.00% | – |
| Q2 2023 | $24,000 | -20.0% | 5,279 | +0.4% | 0.00% | – |
| Q1 2023 | $30,000 | +15.4% | 5,258 | +22.3% | 0.00% | – |
| Q4 2022 | $26,000 | -7.1% | 4,299 | +2.4% | 0.00% | – |
| Q3 2022 | $28,000 | +115.4% | 4,200 | +67.9% | 0.00% | – |
| Q2 2022 | $13,000 | -40.9% | 2,501 | -21.0% | 0.00% | – |
| Q1 2022 | $22,000 | -63.9% | 3,166 | -34.5% | 0.00% | – |
| Q4 2021 | $61,000 | -60.1% | 4,832 | -1.5% | 0.00% | – |
| Q3 2021 | $153,000 | +47.1% | 4,906 | +34.2% | 0.00% | – |
| Q2 2021 | $104,000 | -30.7% | 3,656 | +6.0% | 0.00% | – |
| Q1 2021 | $150,000 | -26.1% | 3,449 | +21.8% | 0.00% | – |
| Q4 2020 | $203,000 | – | 2,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
| Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
| Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
| Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
| HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
| Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
| Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
| ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
| FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |